Filed: 5/18/2026ACC: 0001940272-26-000005
📋 What this filing means
ADAR1 CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 300 equity positions with a total reported market value of $1.70B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
300
Positions
$1.70B
Total AUM (reported)
121.51M
Total Shares
Allocation by class
COM$921.70M54.3%
SPONSORED ADS$201.63M11.9%
COM NEW$152.08M9.0%
SHS$114.08M6.7%
TR UNIT$49.39M2.9%
ALPHA ARCH 1-3$39.20M2.3%
COM SHS$37.62M2.2%
Portfolio Concentration
Top 3$355.92M21.0%
4–10$332.91M19.6%
11–25$306.83M18.1%
Rest$703.01M41.4%
Top 3 weight
21.0%
Top 10 weight
40.6%
Voting Authority Distribution
Total shares with voting rights: 117.86M
Sole
Full voting authority
117.86M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole300
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings300
Rows:
ABIVAX SA
SOLEShares1.44M
TypeSH
Market value$160.12M
9.43%
Sole
0.00
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares994.12K
TypeSH
Market value$104.78M
6.17%
Sole
994.12K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares3.29M
TypeSH
Market value$91.02M
5.36%
Sole
3.29M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares2.68M
TypeSH
Market value$66.55M
3.92%
Sole
2.68M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares1.11M
TypeSH
Market value$58.77M
3.46%
Sole
914.70K
Shared
0.00
None
0.00
STATE STR SPDR S&P 500 ETF T
SOLEShares75.94K
TypeSH
Market value$49.39M
2.91%
Sole
75.94K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares632.56K
TypeSH
Market value$41.69M
2.45%
Sole
632.56K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares1.14M
TypeSH
Market value$41.38M
2.44%
Sole
1.14M
Shared
0.00
None
0.00
EA SERIES TRUST
SOLEShares337.13K
TypeSH
Market value$39.20M
2.31%
Sole
337.13K
Shared
0.00
None
0.00
DENALI THERAPEUTICS INC
SOLEShares1.87M
TypeSH
Market value$35.93M
2.12%
Sole
1.87M
Shared
0.00
None
0.00
BEAM THERAPEUTICS INC
SOLEShares1.45M
TypeSH
Market value$34.47M
2.03%
Sole
1.45M
Shared
0.00
None
0.00
ZAI LAB LTD
SOLEShares1.43M
TypeSH
Market value$26.81M
1.58%
Sole
1.43M
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares1.09M
TypeSH
Market value$26.19M
1.54%
Sole
1.09M
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares2.74M
TypeSH
Market value$24.59M
1.45%
Sole
2.74M
Shared
0.00
None
0.00
DBV TECHNOLOGIES S A
SOLEShares1.01M
TypeSH
Market value$21.16M
1.25%
Sole
1.01M
Shared
0.00
None
0.00
ANTERIS TECHNOLOGIES GLOBAL
SOLEShares3.79M
TypeSH
Market value$21.03M
1.24%
Sole
3.79M
Shared
0.00
None
0.00
INSPIRE MED SYS INC
SOLEShares405.20K
TypeSH
Market value$20.90M
1.23%
Sole
405.20K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares407.27K
TypeSH
Market value$20.02M
1.18%
Sole
407.27K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares211.45K
TypeSH
Market value$18.39M
1.08%
Sole
211.45K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares338.32K
TypeSH
Market value$17.07M
1.00%
Sole
338.32K
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC.
SOLEShares3.41M
TypeSH
Market value$16.03M
0.94%
Sole
3.41M
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares1.58M
TypeSH
Market value$15.37M
0.90%
Sole
1.58M
Shared
0.00
None
0.00
SANOFI SA
SOLEShares316.94K
TypeSH
Market value$15.27M
0.90%
Sole
316.94K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares259.14K
TypeSH
Market value$15.06M
0.89%
Sole
259.14K
Shared
0.00
None
0.00
MONOPAR THERAPEUTICS INC
SOLEShares264.28K
TypeSH
Market value$14.48M
0.85%
Sole
264.28K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ABIVAX SASOLE | SPONSORED ADS | 1.44M | SH | $160.12M 9.43% | 0.00 | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 994.12K | SH | $104.78M 6.17% | 994.12K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 3.29M | SH | $91.02M 5.36% | 3.29M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 2.68M | SH | $66.55M 3.92% | 2.68M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 1.11M | SH | $58.77M 3.46% | 914.70K | 0.00 | 0.00 |
STATE STR SPDR S&P 500 ETF TSOLE | TR UNIT | 75.94K | SH | $49.39M 2.91% | 75.94K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 632.56K | SH | $41.69M 2.45% | 632.56K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 1.14M | SH | $41.38M 2.44% | 1.14M | 0.00 | 0.00 |
EA SERIES TRUSTSOLE | ALPHA ARCH 1-3 | 337.13K | SH | $39.20M 2.31% | 337.13K | 0.00 | 0.00 |
DENALI THERAPEUTICS INCSOLE | COM | 1.87M | SH | $35.93M 2.12% | 1.87M | 0.00 | 0.00 |
BEAM THERAPEUTICS INCSOLE | COM | 1.45M | SH | $34.47M 2.03% | 1.45M | 0.00 | 0.00 |
ZAI LAB LTDSOLE | ADR | 1.43M | SH | $26.81M 1.58% | 1.43M | 0.00 | 0.00 |
SEPTERNA INCSOLE | COM | 1.09M | SH | $26.19M 1.54% | 1.09M | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 2.74M | SH | $24.59M 1.45% | 2.74M | 0.00 | 0.00 |
DBV TECHNOLOGIES S ASOLE | SPONSORED ADS | 1.01M | SH | $21.16M 1.25% | 1.01M | 0.00 | 0.00 |
ANTERIS TECHNOLOGIES GLOBALSOLE | COM | 3.79M | SH | $21.03M 1.24% | 3.79M | 0.00 | 0.00 |
INSPIRE MED SYS INCSOLE | COM | 405.20K | SH | $20.90M 1.23% | 405.20K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 407.27K | SH | $20.02M 1.18% | 407.27K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 211.45K | SH | $18.39M 1.08% | 211.45K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 338.32K | SH | $17.07M 1.00% | 338.32K | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INC.SOLE | COM | 3.41M | SH | $16.03M 0.94% | 3.41M | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 1.58M | SH | $15.37M 0.90% | 1.58M | 0.00 | 0.00 |
SANOFI SASOLE | SPONSORED ADR | 316.94K | SH | $15.27M 0.90% | 316.94K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 259.14K | SH | $15.06M 0.89% | 259.14K | 0.00 | 0.00 |
MONOPAR THERAPEUTICS INCSOLE | COM NEW | 264.28K | SH | $14.48M 0.85% | 264.28K | 0.00 | 0.00 |
Page 1 of 12
…